What it is
- A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on a pineal gland extract studied mainly in Russia.
What researchers have investigated
- Studied in cell, animal and a small number of human studies, often from a single research group, focusing on telomeres and aging markers.
Type of evidence
- Preclinical, plus limited human studies with methodological limitations and little independent replication.
What remains unknown
- Whether any lifespan or aging-related claims hold in rigorous, independent human trials.
Safety & regulatory context
- Not FDA approved for human use. Verify status individually.
Inclusion does not imply availability.
Level Health does not sell, prescribe or recommend Epitalon. Findings in animals or cells do not establish benefits in people.
Primary sources: PubMed search for Epitalon. Reviewed by: pending. Last reviewed: pending.